Jenene Thomas
Investor Relations Kontakt bei LIFE CARE MEDICAL DEVICES LTD
Aktive Positionen von Jenene Thomas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LIFE CARE MEDICAL DEVICES LTD | Investor Relations Kontakt | - | - |
AIM IMMUNOTECH INC. | Investor Relations Kontakt | - | - |
Jenene Thomas Communications LLC | Vorstandsvorsitzender | - | - |
Karriereverlauf von Jenene Thomas
Ehemalige bekannte Positionen von Jenene Thomas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
UNIGENE LABORATORIES INC | Verwaltungsdirektor | 08.09.2011 | - |
Investor Relations Kontakt | 08.09.2011 | - | |
Public Communications Contact | 24.11.2010 | - | |
TYME TECHNOLOGIES, INC. | Investor Relations Kontakt | - | - |
KINTARA THERAPEUTICS, INC. | Investor Relations Kontakt | - | - |
MEDAVAIL HOLDINGS, INC. | Investor Relations Kontakt | - | - |
Public Communications Contact | - | - | |
DARA BIOSCIENCES INC | Investor Relations Kontakt | - | - |
AMICUS THERAPEUTICS, INC. | Investor Relations Kontakt | - | 09.11.2011 |
Public Communications Contact | 08.07.2009 | - | |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | - | - |
Statistik
International
Vereinigte Staaten | 10 |
Kanada | 2 |
Operativ
Investor Relations Contact | 8 |
Public Communications Contact | 4 |
Chief Administrative Officer | 1 |
Sektoral
Health Technology | 10 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
AETERNA ZENTARIS INC. | Health Technology |
AMICUS THERAPEUTICS, INC. | Health Technology |
KINTARA THERAPEUTICS, INC. | Health Technology |
AIM IMMUNOTECH INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Unigene Laboratories, Inc.
Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
Life Care Medical Devices Ltd.
Life Care Medical Devices Ltd. Medical SpecialtiesHealth Technology Life Care Medical Devices Ltd. is a medical device manufacturing company. It engages in the production and distribution of medical device technologies. The company's product in its pipeline, the KeyHole Cup, is a proprietary device now available for use in laparoscopic surgery. Its two initial platforms for market cover laparoscopic surgery (KeyHole Cup) and pain management (Epios). The company's product in its pipeline include the KeyHole Cup, is a proprietary device now available for use in laparoscopic surgery. Its two initial platforms for market cover laparoscopic surgery (KeyHole Cup) and pain management (Epios). Life Care Medical Devices was founded by Glenn S. Foley and Arthur Raymond Malvett on March 26, 2008 and is headquartered in New Smyrna Beach, FL. | Health Technology |
DARA BioSciences, Inc.
DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
MYOS RENS Technology, Inc.
MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
Jenene Thomas Communications LLC | |
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Börse
- Insiders
- Jenene Thomas
- Erfahrung